New renal disease biotech R1 Therapeutics nabs $77.5M for Phase 2bnews2026-03-17T11:00:34+00:00March 17th, 2026|Endpoints News|
J&J pulls out of NYC biotech incubator as it shrinks locationsnews2026-03-17T11:00:29+00:00March 17th, 2026|Endpoints News|
China mRNA therapy startup Innorna to test gout treatment in USnews2026-03-17T11:00:08+00:00March 17th, 2026|Endpoints News|
New studies highlight emerging potential of aluminium(I) chemistrynews2026-03-17T09:30:00+00:00March 17th, 2026|Chemistry World|
